This paper provides a clinical overview of schizophrenia, including the diagnostic criteria established by the DSM, five recognized subtypes (paranoid, disorganized, catatonic, undifferentiated, and residual), and associated neurobiological findings such as brain ventricle enlargement and reduced frontal lobe activity. The paper examines epidemiological data including age of onset, prevalence, and genetic risk factors, with particular attention to concordance rates in relatives and identical twins. Treatment approaches emphasizing medication management with traditional antipsychotics and newer agents are reviewed, along with common side effects including anticholinergic effects, orthostatic hypotension, and akathisia. The dopamine hypothesis is presented as a key neurochemical model for understanding schizophrenia etiology.
According to the Diagnostic and Statistical Manual (DSM), schizophrenia is diagnosed when an individual exhibits two or more of the following characteristic symptoms, each present for a significant portion of time during a one-month period (or less if successfully treated):
1) Delusions; 2) Hallucinations; 3) Disorganized speech (e.g., frequent derailment or incoherence); 4) Grossly disorganized or catatonic behavior; and 5) Negative symptoms (i.e., affective flattening, alogia, or avolition).
Paranoid Type is characterized by preoccupation with one or more delusions or frequent auditory hallucinations, with none of the following as prominent: disorganized speech, catatonic behavior, or flat or inappropriate affect. This subtype typically presents with relatively preserved cognitive functioning and social competence outside the delusional content.
Disorganized Type is characterized by prominent disorganized speech, disorganized behavior, and flat or inappropriate affect. Individuals with this subtype often display severely disrupted functioning across multiple domains.
Catatonic Type is defined by the presence of at least two of the following features: motoric immobility, excessive and purposeless motor activity, negativism or mutism, and peculiarities of voluntary movement or echolalia. Motor symptoms are the defining feature of this presentation.
Undifferentiated Type describes individuals who meet the diagnostic criteria for schizophrenia but do not meet the criteria for any of the other subtypes.
Residual Type describes someone who has had at least one episode of schizophrenia, but now there is an absence of prominent delusions, hallucinations, and disorganized or catatonic behavior. However, some negative symptoms or milder forms of the previously described symptoms remain present.
Neuroimaging and structural studies have revealed several consistent findings in individuals with schizophrenia. Brains of schizophrenia patients show enlargement of the lateral and third ventricles, as well as a smaller cerebral cortex and a smaller thalamus. PET scans show that individuals with schizophrenia have decreased frontal lobe activity. Frontal lobe abnormalities have been strongly associated with the negative symptoms of schizophrenia (e.g., flat affect, avolition, and amotivation).
The age of onset for schizophrenia typically appears in the late teens to early twenties. According to the DSM-IV, the median age of onset is in the early to mid-twenties for men and in the late twenties for women. Schizophrenia is more common among persons of lower socioeconomic status. The male-to-female ratio is approximately equal.
Prognosis is generally best with good prior functioning, late onset, abrupt onset, comorbid mood disorder, identifiable stressor, paranoid subtype presentation, and female gender.
Schizophrenia has a prevalence rate of approximately 1% in the general population. Genetic factors play a significant role in risk. First-degree relatives (i.e., siblings) have a concordance rate of 10%. Identical twins have a 50% concordance rate. When both parents have the disorder, the risk of developing schizophrenia is 45%. Relatives of individuals with schizophrenia have an increased risk of developing other schizophrenia spectrum disorders, including schizotypal and paranoid personality disorder, and other nonaffective psychotic disorders (e.g., delusional disorder).
"Antipsychotics, side effects, and dopamine model"
Always verify citation format against your institution’s current style guide requirements.